doctors and drug companies doctors and drug companies

Patients with private insurance like the drug coupons because they can help make specialty medicines more affordable. But health care analysts say the coupons may also discourage patients from considering appropriate lower-cost alternatives, including generic drugs. DNY59/Getty Images hide caption

toggle caption
DNY59/Getty Images

A single company, Purdue Pharma, the maker of OxyContin, funneled $4.7 million to advocacy groups over the five-year period, according to the report. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

A study of chemotherapy medicines produced by 10 companies found that, on average, each drug produced seven times as much revenue for its manufacturer as it cost in research and development. BrianAJackson/iStockphoto/Getty Images hide caption

toggle caption
BrianAJackson/iStockphoto/Getty Images

R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds

  • Download
  • <iframe src="https://www.npr.org/player/embed/550135932/550218516" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An aggressive marketing campaign has made the EpiPen the go-to drug for treating anaphylaxis. Mark Zaleski/AP hide caption

toggle caption
Mark Zaleski/AP

EpiPen Manufacturer Says It Will Help With Out-Of-Pocket Costs

  • Download
  • <iframe src="https://www.npr.org/player/embed/491232665/491311810" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript